BioStar Pharmaceuticals, Inc.(Other OTC/NBB : BSPM)
BSPM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.45%||178.89||0.7%||$1413.67m|
|BMY||Bristol-Myers Squibb Co.||1.73%||78.24||1.0%||$1172.57m|
|MRK||Merck & Co., Inc.||0.85%||93.10||0.7%||$1086.85m|
|LLY||Eli Lilly & Co.||0.70%||301.48||1.1%||$869.46m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.64%||141.50||0.0%||$430.00m|
|HZNP||Horizon Therapeutics Plc||2.29%||92.90||5.4%||$202.12m|
|NVO||Novo Nordisk A/S||3.02%||106.36||0.1%||$174.32m|
BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. It's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting the Chinese population. The company was founded on March 27, 2007 and is headquartered in Xianyang, China.